UNM Q1 2026 Earnings EPS Surpasses Estimates Amid Modest Stock Decline NRX Pharmaceuticals Q1 2026 Earnings EPS Miss Marks 114 Surprise Shortfall Stock Surges 20 Olema Pharmaceuticals Inc OLMA Q1 2026 Earnings NarrowerThanExpected Loss Amid Ongoing Clinical Progress KORE Q1 2026 Earnings Earnings Miss Estimates by Wide Margin Stock Reacts Modestly PAHC Q1 2026 Earnings EPS Surpasses Expectations Amid Operational Strength NiSource NI Q1 2026 Earnings Earnings Miss the Mark but Stock Edges Higher